NS · Healthcare

Brawn Biotech Ltd (530207)

Pharmaceuticals & Biotechnology

Brawn Biotech Ltd (530207) is listed on NS in the Healthcare sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $63.00M, P/E ratio is 6.71, net margin is -5.7%, dividend yield is 4.76%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for 530207

Market cap

$63.00M

P/E ratio

6.71

Net margin

-5.7%

Dividend yield

4.76%

Brawn Biotech Ltd (530207) — FAQ

What is Brawn Biotech Ltd's market cap?

Brawn Biotech Ltd (530207) has a reported market cap of $63.00M (data as of 2026-07-10).

What is 530207's P/E ratio?

The price-to-earnings (P/E) ratio for Brawn Biotech Ltd (530207) is 6.71 (data as of 2026-07-10).

Does Brawn Biotech Ltd pay a dividend?

Brawn Biotech Ltd (530207) shows a reported dividend yield of 4.76%. Open the MyAverix Finance app for dividend history and payout details (data as of 2026-07-10).

What sector is Brawn Biotech Ltd in?

Brawn Biotech Ltd (530207) is classified in the Healthcare sector (Pharmaceuticals & Biotechnology industry).

What exchange is 530207 listed on?

530207 is listed on NS.

What is Brawn Biotech Ltd's net margin?

Brawn Biotech Ltd (530207) reports a net margin of -5.7% (data as of 2026-07-10).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

09R (09R) 10X GENOMICS DL -00001 (1KJ) 160 Health International Ltd (2656) 1CM INC. (IQ70) 2cureX AB (2CUREX) 3-D Matrix Ltd (DMTRF) 3D Global Biotech Inc. (6808) 3D Medicines Inc (1244)